← Open Payments lookup

CAMILLE MEYHOFF: Open Payments

NPI 1720187669 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$937 in 55 payments from 18 companies in 2025. Trend: 2023 $970 · 2024 $839 · 2025 $937

Food & beverage: $937
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation15$195
PFIZER INC.10$168
Actelion Pharmaceuticals US, Inc.3$71
Amgen Inc.4$66
Merck Sharp & Dohme LLC4$60
Alnylam Pharmaceuticals Inc.3$52
United Therapeutics Corporation2$44
BridgeBio Pharma, Inc.2$33
Philips North America LLC1$33
LeMaitre Vascular, Inc.1$33

Products named: LEQVIO, ELIQUIS, UPTRAVI, REPATHA, VERQUVO, VYNDAQEL, AMVUTTRA, Tyvaso.

Industry payments across ND — which companies pay providers there.